Selank

Selank is a synthetic heptapeptide constructed as a structural analog of the endogenous immunomodulatory tetrapeptide tuftsin. Additional proline residues in its sequence increase resistance to enzymatic breakdown and thereby extend its laboratory half-life relative to native tuftsin. In research settings the compound is employed exclusively as a tool for examining peptide-mediated interactions between neural and immune pathways. All work remains confined to in-vitro assays and controlled experimental model systems.

Laboratory studies investigate Selank for its capacity to modulate GABAergic neurotransmission and related inhibitory signaling cascades in neuronal preparations. Parallel work examines its influence on monoaminergic systems and on the expression of brain-derived neurotrophic factor (BDNF). Researchers also explore effects on enkephalin-degrading enzymes that regulate endogenous opioid peptide turnover. These interactions are characterized through biochemical assays, receptor-binding experiments, and gene-expression analyses.

Principal research applications center on models of anxiety-related signaling and cognitive processes within laboratory frameworks. Investigators use Selank to probe regulation of neurotrophic factors, monoamine balance, and enkephalin metabolism. A further focus is its dual action on immune signaling pathways, enabling examination of neuro-immune cross-talk. The peptide’s combined stability and multi-system profile make it useful for dissecting these interactions under strictly controlled experimental conditions.

In-vitro and model-system studies have reported that Selank can alter expression patterns of genes linked to GABA receptors and BDNF. Experimental data also indicate modulation of enkephalinase activity, thereby affecting peptide degradation kinetics. Additional observations describe changes in selected cytokine profiles and immune-cell responses under defined laboratory conditions. All such findings derive from controlled assays and remain limited to research contexts.

Selank retains the core tuftsin sequence Thr-Lys-Pro-Arg and is extended by the tripeptide Pro-Gly-Pro. This modification markedly reduces susceptibility to peptidases, conferring greater metabolic stability in experimental media. The prolonged presence of intact peptide facilitates time-course studies that would be impractical with rapidly degraded native tuftsin. Structural integrity is routinely verified by chromatographic and mass-spectrometric methods prior to use.

Selank is supplied solely for in-vitro laboratory research and experimental model systems. Standard peptide-handling practices apply, including storage at low temperature and reconstitution under sterile conditions with appropriate solvents. Investigators must follow institutional biosafety and chemical-hygiene protocols. The material is not intended for any form of administration outside pure research applications.